Lupin 2024

August 22, 2022

You can read the full August 22 print issue of Chain Drug Review in its entirety here. In CDR’s digital editions, you can find special sections and additional pages not posted online. You will need to register, but subscription is free!

Sephora has competition from these Chinese beauty stores

Sephora has competition from these Chinese beauty stores

Beauty collection stores are quickly growing in China — as Chinese consumers’ appetite for beauty products continues to evolve. Most people’s first thought may be Sephora, Watsons or Mannings, where customers can get access to a wide range of skin care, makeup and fragrance products. The biggest advantage these retailers have is their wide selection

Manage the product journey tightly to the very end

Manage the product journey tightly to the very end

Controlling the product journey all the way from planogram to the shopping basket isn’t easy but, to deliver the shopping experience you want for your customers, you must find a way. With the right resources (internal or trusted partners) you can maintain control of your product assets to protect the quality and integrity of your

Pharmacies need employee-centric cultures to thrive

Pharmacies need employee-centric cultures to thrive

Today’s workers value different things. They want flexibility, demand a work culture that recognizes their worth, and are willing to change jobs to find what they want now. This shift has been particularly challenging in retail pharmacy as many workers are less tolerant of the often hectic and demanding environment. As a result, an increased

New revenue streams and alliances reinvent drug chain

New revenue streams and alliances reinvent drug chain

If, like me, you think that the quote from Heraclitus, “The only thing constant is change,” would be a gross understatement to describe the next few years for chain drug, read on. If, on the other hand, you are neither fascinated nor concerned with the external uncertainties of the country right now and the strategies

A look at health, wellness ad dollars

A look at health, wellness ad dollars

Pharma and Wellness sectors naturally represented a key focus in the U.S. advertising industry during calendar-year 2021. As the pandemic evolved over time, marketers in the space navigated uncertain times, with health and wellness concerns remaining a particular, top-of-mind presence for consumers. With such opportunity for contextual relevance, Pharma and Wellness ad spend remained a

Beauty consumers seek richer in-store experience

Beauty consumers seek richer in-store experience

According to a study released earlier this year by Kline and Co., “Cosmetics and Toiletries USA,” the U.S. beauty and personal care market surpassed $85 billion in retail sales in 2021, a rise of $7 billion from 2019 sales levels. This marks the sector’s strongest performance within the last 10 years, with no signs of

Three trends are recasting chain drug retailers’ front ends

Three trends are recasting chain drug retailers’ front ends

Coresight Research expects wellness to remain the pre-eminent multiyear trend driving consumer spending shifts, only amplified by the pandemic prompting consumers to focus more on mental and physical wellness. Here, we discuss three notable trends in drug-store-relevant consumer packaged goods categories: demand for clean beauty, a drive toward personalized nutrition and acquisitions of startups. Demand

Beauty brands’ new role in the metaverse

Beauty brands’ new role in the metaverse

There’s a lot of buzz around the metaverse right now and how it might reshape the future of retail. And for good reason. Being able to inhabit persistent, decentralized and shared virtual spaces, and move seamlessly between them and the real world, will open up countless new opportunities for beauty brands. The ultimate vision for

Pull out all the stops to boost traffic in challenging times

Pull out all the stops to boost traffic in challenging times

2021 was an immensely challenging year for retail pharmacy chains — as pharmacy chains were tasked with the rollout and administration of COVID-19 vaccines. As vaccine-seekers rushed to stores foot traffic and subsequent discretionary purchases increased. There was a 7% increase in discretionary transactions as revenues for major pharmacy chains increased by 6% to $328

Expect a global collision in consumer health care

Expect a global collision in consumer health care

The pandemic years have changed the U.S. consumer health care products and services world. Evolution and revolution on a global scale confront U.S. chain drug stores and independent pharmacies alike. The rapper Tupac Shakur once said, “You either ride with us or collide with us.” Both are happening. The consumer health care world is riding

Auto-replenishment meets needs and saves money

Auto-replenishment meets needs and saves money

Current economic pressures on chain drug retailers are intensifying — in addition to tremendous cost pressure on inventory, the cost of labor is up. All while labor shortages faced by many in the industry create additional operational challenges. At the same time, the shape of the prescription drug industry is changing, with emerging offerings like

Borne of e-commerce, retail media is here to stay

Borne of e-commerce, retail media is here to stay

The COVID-driven shift to e-commerce has profoundly impacted commerce. As shoppers flock online in droves, 75% of they report changing brands during the pandemic, and many won’t go back to previous brand loyalties. Brands have scrambled with supply chain disruptions and activating the shopper in this new omni-commerce world, including shifting their connection points with

PP_1170x120_10-25-21